In keeping with Dr Peter Beaconsfield’s vision for the medical sciences, and the importance the Division places on the scientific/clinical interface, this prize is intended to reward young researchers who engage with translational medicine, and display a wider grasp of the significance and potential applicability of their research.
'Translational medicine' is given to mean the immediate interface between basic and clinical science, where advances in the basic sciences are examined for their possible implications for the prevention, diagnosis and treatment of disease and where clinicians challenge basic science for the answers to clinically relevant questions.
Of her winning submission, Kristie said "My essay examined the influence of factors, present in the tumour microenvironment, on the actions of anti-cancer drugs, and the implications of this for the treatment of advanced prostate cancer."
For more information about the prize and eligibility for next year's award, please click here.
Congratulations Kristie on your award!